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Dopamine (DA) is one of the most important catecholamine neurotransmitters of the human central
nervous system, and is involved in many behavioral responses and brain functions. Below normal DA
levels in biological ﬂuids can lead to different neurodegenerative conditions. For excess DA levels, a
failure in energy metabolism is indicated. In this study, a facile room-temperature phosphorescence
sensor is developed to detect DA based on L-cysteine capped Mn doped ZnS quantum dots (L-cys ZnS:Mn
QDs). The QDs display a prominent orange emission band peaking at 598 nm, which is strongly
quenched upon addition of DA in alkaline medium. The sensor exhibits a linear working range of 0.15–
3.00 μM, and a limit of detection of 7.80 nM. These results are explained in terms of a pH-dependent
electron transfer process, in which the oxidized dopamine quinone functions as an efﬁcient electron
acceptor. The QDs-based sensor shows a high selectivity to DA over common interfering biomolecules
(including some amino acids, ascorbic acid, chloride and glucose). The sensor has been successfully
applied for the detection of DA in urine samples, yielding recoveries as high as 93%. Our ﬁndings indicate
that our developed sensor exhibits high sensitivity and reproducibility to determine DA even in biological
ﬂuids where DA is at low levels, e.g., in the central nervous system, which is the usual clinical proﬁle of a
neurodegenerative disorder associated to the Parkinson's disease.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The US National Institute of Neurological Disorders classiﬁes
Parkinson’s disease as the second most common neurodegenera-
tive disorder, affecting approximately one million people in the US
(Yao et al., 2013). This disease is related to the loss of brain cells
that produce dopamine (DA). DA is one of the most important
catecholamine neurotransmitters of the human central nervous
system, and is involved in many behavioral responses and brain
functions (Mu et al., 2014). The normal levels of DA vary de-
pending on its location in the nervous system, and fall within the
range of 1–50 nM in the brain extracellular ﬂuid. Abnormal levels
of DA have been associated to several diseases. For instance,
schizophrenia and aprosexia can result from deﬁcient levels of DA,B.V. This is an open access article u
search Center, University of
stra),while pleasurable/rewarding feelings (even euphoria) and failure
in energy metabolism are observed when DA is in excess (Hyman
et al., 2001; Mu et al., 2014; Tobler et al., 2005). This makes the
selective and sensitive detection of DA of paramount importance
in health clinics and the pharmaceutical industry. Among the most
used techniques to detect DA are colorimetry, chemiluminescence,
gas and liquid chromatography, and electrochemical approaches
(Alarcon-Angeles et al., 2008; Naccarato et al., 2014; Li et al.,
2011a; Su et al., 2012; Ye et al., 2005). Nonetheless, there exist
some limiting factors (including long operation times, overlapping
signals, cumbersome methods of extraction, and interference from
other biological molecules) that hinder their performance (Ban
et al., 2015). To surmount these difﬁculties, room temperature (RT)
ﬂuorescence has been recently proposed due to its high sensitivity,
detection reliability, safe manipulation, operational simplicity,
real-time detection, and cost-effectiveness (Zhang et al., 2015a).
The detection process of this spectroscopic technique is based on
the effective interaction between the target analytes (such as
metal ions and biomolecules) and ﬂuorescent probes, whichnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Quantum dots (QDs) used as ﬂuorescent probes in chemo/
biosensing offer signiﬁcant advantages over organic molecules,
genetically-encoded ﬂuorophores and conventional dyes, in terms
of simultaneously detecting multiple signals, producing long-term
stabilities, and enriching both the biological targeting efﬁciency
and substrate speciﬁcity (Alivisatos, 1996; Diaz-Diestra et al., 2015;
Liao et al., 2014). In particular, Mn-doped ZnS (ZnS: Mn) QDs with
intrinsic solubility in water have appeared as a potential ﬂuor-
escent probe since they exhibit high resistance to photobleaching,
broad absorption with relatively-narrow and symmetric emission,
high quantum yield, and strong resistance to degradation. Their
main features are not only analogous to those observed in Cd (Se,
Te) QDs (most used as standards), but also ZnS:Mn QDs are non-
toxic in a wide range of concentrations (Diaz-Diestra et al., 2015; Li
et al., 2011b; Sotelo-Gonzalez et al., 2013; Zhang et al., 2011). In
addition, the Mn-doping into the ZnS host further advances mul-
tiplicity of decay times, ﬂexible bioconjugation approaches, en-
hanced surface passivation, large-effective Stokes shifts, inter-
mittency under continuous excitation, and optical tunability (Diaz-
Diestra et al., 2015; Liu et al., 2008a; Quan et al., 2009). Thus, ZnS:
Mn can serve as a promising ﬂuorescent nanoplatform with ad-
vantages over traditional detection systems. Its optical sensing is
based on the interaction of a fraction of atoms/molecules on a
treated surface, which strongly affects the recombination of elec-
trons and holes within the particles, and in turn the emission re-
sponse (Mu et al., 2014). Following this process, many analytes
have been successfully detected, such as ions (Hg2þ , Co2þ , Zn2þ
and Zr4þ) (Bian et al., 2014; Gong et al., 2014a; Ren et al., 2011; Tan
et al., 2012); proteins/enzymes, clenbuterol and glucose in biolo-
gical ﬂuids (Gong et al., 2014b; Wu et al., 2013; Wu et al., 2010;
Zhang et al., 2013); organophosphorus pesticides (Ban et al., 2014);
phenols in different media (Liu et al., 2010; Wei et al., 2015; Zhang
et al., 2015b); and cathecol, domoic acid, rutin, urea, idarubicin
and DNA (Bi et al., 2014; Dan et al., 2013; Ertas et al., 2015; Miao
et al., 2014; Wang et al., 2013). Recently, Bian and co-workers,
employing N-acetyl-L-cysteine and L-cysteine capped ZnS:Mn QDs
as probes, showed the luminescent detection of L-ascorbic acid
(AA) with high selectivity and long luminescence lifetime (Bian
et al., 2013). The authors exploited the fact that the RT luminescent
intensity of the Mn-emission band is efﬁciently quenched by AA,
which is converted into dehydro-AA via oxidation when exposed
to Mn3þ ions. The ZnS:Mn optical sensor exhibited a linear
working range of 2.5–47.5 mM with limits of detection (LOD) from
0.72 to 1.38 mM (Bian et al., 2013). Similarly, Zhang and co-workers
modiﬁed the surface of ZnS:Mn nanocrystals with DA dithio-
carbamate to detect diethylphosphorothioate (DEP) (Zhang et al.,
2014). Modulating the dual emission of ZnS:Mn probe through a
photo-induced electron transfer process, the authors enhanced the
red emission by switching off the electron transfer pathway and
keeping the blue emission almost unaltered. They obtained a lin-
ear response for DEP concentrations with a LOD of 1.8 mM (Zhang
et al., 2014). However, even though the manganese energy levels
in surface-modiﬁed ZnS:Mn QDs can facilitate the detection of
certain analytes, the quenching effect of DA on the Mn-emission
band of ZnS:Mn has not been studied. In addition, the interaction
mechanism of DA with other QDs is still unclear to date.
Over the past few years, the interaction of DA with QDs has
been assessed in bioconjugates and expressed in terms of redox
interactions, in which DA quinone acts as an electron donor that
quenches or sensitizes the QDs via a reactive oxygen-mediated
mechanism (Clarke et al., 2006). It has been also reported that
such bioconjugates function as charge-transfer coupled pH sen-
sors, wherein DA is characterized by both the Nernstian depen-
dence of formal potential on pH, and the oxidation of hydro-
quinone to quinone by O2 at basic pH (Medintz et al., 2010). Thissigniﬁes that the oxidized DA acts as an electron acceptor that
quenches the QDs emission depending directly on pH. More re-
cently, Qin and co-workers showed that the QDs-DA interactions
could modulate the ﬂuorescence and photoresponse of the DA-
arginine-glycine-aspartic-acid-cysteine QDs system by speciﬁc
trypsin activity (Qin et al., 2014). The authors reported that the
ﬂuorescence signal signiﬁcantly increased as a result of the en-
zymatic cleavage of the active molecules, and that the photo-
current was enhanced as the trypsin concentration increased from
0 to 15 mg mL1 (Qin et al., 2014). Mu and co-workers built a DA
ﬂuorescent sensor based on adenosine-capped CdSe/CdS/ZnS QDs,
and found a LOD of 20 nM with a linear working range of
100 nM to 20 μM, which was ascribed to the strong interaction
between adenosine and DA (Mu et al., 2014). In parallel, Xiangzhao
and co-workers reported that the silica-capped CdTe based sensor
can detect DA in the range of 500 nM to 100 μM with a LOD of
240 nM, which was associated to the hydrogen bonding and
electrostatic interaction between silica and DA in alkaline solution
(Xiangzhao et al., 2013). Although the interaction of DA with Cd-
based QDs in the form of bioconjugates has been studied under
certain conditions, the selective capture of DA molecules by sur-
face-complexed ZnS:Mn QDs via a phosphorescent quenching
process is still a big challenge. In this paper, we report for the ﬁrst
time the development of a room-temperature phosphorescence
sensor based on L-cysteine (L-cys) capped ZnS:Mn QDs synthesized
via a facile wet chemical approach, to detect DA in a wide range of
concentrations (nM-mM). The advantage of using L-cysteine (a
natural thiol-containing amino acid with excellent water solubi-
lity) is the fact that it endows L-cys capped ZnS:Mn QDs with
further biocompatibility and great potential for room temperature
detection of water-soluble analytes (such as dopamine) in biolo-
gical ﬂuids. In order to make our sensor more selective, we eval-
uate the discrimination of the DA detection from seven interfering
analytes. Finally, we examine the accuracy of our method in real
samples to determine DA in urine samples via a recovery test.2. Experimental section
2.1. Synthesis of L-cysteine capped ZnS:Mn quantum dots
ZnS:Mn QDs capped with L-cysteine (C3H7NO2S,Z98.5%, Sigma
Aldrich, USA) were prepared by an inorganic wet chemical ap-
proach, following our previous synthetic methodology (Diaz-
Diestra et al., 2015) with some modiﬁcations. Brieﬂy, 90 mg of
ZnSO4 H2O (Z99.9%, Sigma Aldrich, USA), 3.0 mg of MnCl2
(Z99%, Sigma Aldrich, USA) and 121 mg of L-cysteine were dis-
solved into a 25 mL three-neck round-bottom ﬂask using high-
purity deionized water (HPDW), resulting in a 5 wt% Mn doping.
The pH of the mixed solution was adjusted to 11 using 1 M NaOH
(99.99%, Sigma Aldrich, USA). After purging with argon, 5 mL of
0.2 M aqueous solution of Na2S (Sigma Aldrich, USA) was gradually
added. The mixture was stirred under controlled reﬂux for 14 h at
50 °C in open air. The ﬂocculate was removed from the super-
natant by ultracentrifugation, and copiously rinsed with HPDW,
and then freeze-dried. The ﬁnal products were re-dispersed in
HPDW and produced a deep orange solution when exposed to UV
light. This orange color is a clear indicator of the compound for-
mation, and is used for ex-situ characterization throughout the
experiments.
2.2. Apparatus
The optical absorption spectra were recorded using a UV–vis
spectrophotometer (DU 800, Beckman Coulter). A Cary Eclipse
Spectrophotometer was employed to collect the emission spectra
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from 400 to 700 nm, using slit widths of 10 and 20 nm for emis-
sion and excitation, respectively. The phase and crystalline struc-
tures of the QDs were analyzed using an X-Ray Diffractometer
(XRD), Rigaku Smart-Lab Japan, equipped with a Cu Kα radiation
source, and operated at an accelerating potential of 40 kV and a
tube current of 44 mA. The FT-IR spectra were recorded using a
Bruker Tensor 27 in the range of 100–4000 cm1. The surface
morphology and crystallite size distribution were studied using a
JEOL JEM-2200FS Cs-corrected high-resolution transmission elec-
tron microscope (HRTEM) operated at 200 kV.2.3. Phosphorescence quenching of L-cysteine capped ZnS:Mn
quantum dots by dopamine and discrimination of interfering analytes
In separate assays, L-cys capped ZnS:Mn QDs ( 300 mL, pH 7.0)
and DA (0–3000 nM) were placed into 5 mL tubes. The mixtures
were then diluted up to 3 mL using 10 mM PBS (pH 8.0) and mixed
thoroughly. Afterwards, the pH of the ﬁnal solutions were opti-
mized (from 5.0 to 8.5) using 1 M NaOH, and were then excited
with 302 nm light to collect the emission spectra at different times
(0–60 min). A similar procedure was followed for discriminating
DA from seven interfering analytes (KCl, L-histidine, dihydrox-
yphenylacetic acid, L-glutamine, L-glucose, L-aspartic acid and as-
corbic acid (AA) at 10 mM). All the experiments were repeated in
triplicate and performed at RT.2.4. Detection of dopamine in real samples
In order to detect DA in biological ﬂuids, urine samples were
subjected to a 100-fold dilution process using a 10 mM PBS solu-
tion (pH 8.0) before analyses. In a typical assay, different con-
centrations (5–1000 nM) of DA and L-cysteine capped ZnS:Mn QDs
(300 mL, pH 7.0) were mixed with diluted urine. Then, this mixture
was added to a solution consisting of 20 mL DA and PBS obtaining a
ﬁnal volume of 3 mL at pH 8.0. The as-prepared samples were
excited with 302-nm light to collect the emission spectra after
30 min. All the experiments were repeated in triplicate and per-
formed at RT.Fig. 1. Bright-ﬁeld HRTEM images (a, b) of L-cys capped ZnS:Mn QDs. The insets in (a) and3. Results and discussion
3.1. Characterization of L-cysteine capped ZnS:Mn quantum dots
The surface morphology and particle size distribution of the
products synthesized via a one-pot wet chemical approach are
depicted in Fig. 1. The HRTEM image displayed in Fig. 1a shows
thin clusters consisting of particles with high deﬁnition. A closer
look indicates that the particles are near-spherical and homo-
geneously distributed with a high degree of crystallinity, whose
sizes range from 1 to 5 nm (see Fig. 1b). From the gray scale
contrasts, the nanoparticles appear to be composed of another
extra amorphous phase, which is ascribed to the capping layer. The
statistical size distribution obtained by image analysis further
conﬁrmed that the size of nanoparticles falls in the range of 1–
5 nm, with an average particle size of 2.8 nm (see inset of
Fig. 1b). This analysis points out that the nanoparticles are
monodispersed. To assess the nanoparticles’ phase, we carried out
selective area electron diffraction (SAED) on the region shown in
Fig. 1a. The SAED pattern depicted in the inset of Fig. 1a shows
three major diffraction rings, which are indexed to the diffraction
planes of the cubic sphalerite phase of polycrystalline ZnS [(111),
(220) and (311)] according to the JCPDS card, File No. 65–0309
(Diaz-Diestra et al., 2015).
To further conﬁrm the preferential cubic crystallization, we
conducted X-ray diffraction on bulk samples. The XRD pattern
shows three diffraction peaks, which are indexed to the diffraction
planes of stable cubic ZnS (see Fig. S1a). The prominent broad-
ening of the XRD diffraction peaks is ascribed to the nanocrystal-
line nature of ZnS: Mn. No detectable shifts (lattice distortion) of
the diffraction peaks were observed, which is indicative of the
successful random substitution of Mn2þ into Zn2þ sites at 5 wt%
Mn doping. The average crystallite size was calculated to be
2.1 nm by means of Scherrer's formula, in agreement with the
image analysis. Taken altogether, both diffraction techniques and
electron microscopy provide evidence that ZnS:Mn nanoparticles
are free of both parasitic phases and hexagonal ZnS traces, and
they are of high crystalline quality and purity.
To verify the bonding of L-cysteine capping ligand onto the
nanoparticles surface, we conducted an FTIR analysis. The FT-IR
spectra of the L-cys capped ZnS:Mn and L-cysteine are depicted in
Fig. S1b. It is noteworthy that in our synthetic methodology the pH(b) show the SAED rings and particle size distribution of L-cys capped ZnS:Mn QDs.
Fig. 2. The effect of the interaction time (a) and pH (b) on the emission intensity of
L-cys capped ZnS:Mn QDs in the presence of DA.
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of the L-cysteine, and in turn to reinforce the bonding. The FT-IR
spectrum of bare L-cysteine shows a pronounced band at
2600 cm1, which is ascribed to the typical S-H stretching of L-
cysteine (Bian et al., 2013). It was found that this band vanishes
when L-cysteine is linked onto the ZnS:Mn surface, indicating the
successful formation of S–Zn and S-Mn bonds between the ligand
and nanoparticles. The FT-IR spectrum of L-cys capped ZnS:Mn
shows three main absorption bands at 3500–3000 cm1 (mν
OH, COOH), 1550–1600 cm1 (sν COO) and 1400 cm1 (mν
COO), and one absorption band at 2900–3420 cm1, which
correspond to the carboxylic functionality and the amino group,
respectively. This observation conﬁrms that L-cysteine has been
successfully attached on the ZnS:Mn surface, and that an effective
deprotonation process of L-cysteine was achieved, which is evi-
denced by the presence of the carboxylate moieties.
The optical properties of L-cys ZnS:Mn nanoparticles in aqueous
media were studied via UV–vis spectroscopy. The absorption and
emission spectra of L-cys ZnS:Mn nanoparticles are depicted in Fig.
S2. The UV–vis spectrum shows a broad band that reaches a
maximum absorption at 297 nm, which is attributed to the ex-
citon transition of ZnS (Augustine et al., 2013). This represents a
blue shift of 40 nm when compared to bulk ZnS, which is at-
tributed to the quantum conﬁnement effect since the average
crystallite size is comparable to the exciton Bohr radius (2.5 nm)
(Augustine et al., 2013). The same spectral position of this band
was observed for both ZnS and ZnS:Mn QDs, as expected. The
phosphorescent spectrum shows a prominent orange emission
band at 598 nm, which is associated to the internal Mn2þ ion
transition between the 4T1 ﬁrst excited state (spin 3/2) and the 6A1
ground state (spin 5/2) (Beltran-Huarac et al., 2013). Note that the
blue band at 416 nm (ascribed to the nanostructure surface
states) typically observed in dual-emitting ZnS:Mn QDs was not
detected by the spectrometer since it was operated in phosphor-
escence mode (Ertas et al., 2015) The blue band of the QDs when
the spectrometer is operated in ﬂuorescence mode was reported
in our previous work (Diaz-Diestra et al., 2015). The internal
transition is assumed to cause energy transfer from s-p electron-
hole pair band states (host ZnS nanocrystal) to the Mn2þ ion d-
electron states. These results conﬁrm that the incorporation of
Mn2þ ions into the ZnS host was homogeneous.
3.2. Effect of the reaction time and pH on the detection of dopamine
Although the prepared L-cysteine capped ZnS:Mn QDs is stable
in water without visible precipitation after long aging times (few
days), the orange emission band is observed to change as a func-
tion of time and pH. For this reason, the luminescent quenching
effect of the QDs-based sensor is better monitored in phosphate
buffer (PBS) for biological applications. The quenching of L-cys
capped ZnS:Mn QDs luminescence by DA was studied in PBS
media and used to quantify the DA detection. In order to detect DA
with high sensitivity, the interaction time between DA molecules
and L-cys capped QDs, and the pH dependence were ﬁrst opti-
mized. A linear relationship between the luminescence intensity
and the concentration of the QDs over a wide range of con-
centrations, as previously reported, was observed (Ban et al.,
2015). The concentration of the sensing probe was idealized to be
55 mM, which provides a stable and detectable luminescence
signal and avoids oversaturation. This concentration, which is
compatible with that reported to detect other analytes (Bian et al.,
2013), was used for further analysis. The effect of the reaction time
(0–60 min) on the emission intensity of L-cys capped ZnS:Mn QDs
in the presence of 0.8 mM DA is depicted in Fig. 2a. We observed
that as time increases the luminescence intensity gradually de-
creases, which is attributed to the interaction between the DAtarget and L-cys ZnS:Mn probe via a charge transfer mechanism
(Medintz et al., 2010). Fig. 2a also shows that the luminescent
intensity is linear in the range of 0–60 min. We have thus taken
the mean value (30 min) as suitable for the pH-dependent studies.
Although the quenching apparently starts going slow, for instance
in the interaction of DA and nanoclusters (Ban et al., 2015), our
observations indicate that the interaction between DA and ZnS:Mn
takes longer times until reaching the quenching saturation, which
is related to the proper L-cysteine linkage (Qin et al., 2014).
The effect of pH (5.0–8.5) on the emission intensity of L-cys
capped ZnS:Mn QDs in the presence of 0.8 mM DA is depicted in
Fig. 2b. It was found that the luminescence intensity remains es-
sentially the same in the range of 5.0–7.0, and then gradually de-
creases above 7.0 up to a pH value of 8.0. This is due to the fact that
at high pH values, DA is rapidly oxidized to its quinone derivative,
causing in turn an effective reactive quenching of L-cys capped
ZnS:Mn QDs. We observed that the luminescence intensity and the
stability of L-cys capped ZnS:Mn QDs is reduced at pH values
higher than 8.5. This instability could be related to the offset of the
noncovalent binding (caused by the electrostatic repulsion be-
tween the DA anions and the electronegative parts of L-cys capped
QDs), which repels the rebinding of DA. We thereby set the pH to
8.0 as a tradeoff to minimize the DA repulsion and partial autop-
olymerization of the unstable quinone derivative, and the sub-
sequent formation of polydopamine (Ban et al., 2015; Yildirim
et al., 2014; Zhou et al., 2015). The luminescence quenching effect
was further analyzed at this pH for 30 min
Fig. 3. Phosphorescence emission spectra (a) of L-cys capped ZnS:Mn QDs in the presence of different concentrations of DA (0–3000 nM). Stern-Volmer plots of Io/I as a
function of the DA concentration (0–3000 nM) (b). Lower inset shows the expanded linear region of the calibration curve. Upper inset shows the optical images of the
phosphorescence quenching that undergoes the QDs as DA concentration increases (excitation light: 302 nm).
Scheme 1. Depiction illustrating the sensor design and selective dopamine detection through a phosphorescence quenching mechanism.
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quenching
The quenching ability of dopamine on the phosphorescence
emission of L-cys capped ZnS:Mn QDs was recorded by adding
various DA concentrations to the solution (see Fig. 3a). It was ob-
served that the intensities decrease as the DA concentration in-
creases from 0 to 3000 nM (see upper inset). No additional, de-
tectable change in the spectral shape was seen, as expected. Fig. 3b
shows the Stern-Volmer plots of I0/I as a function of the DA con-
centration from 0 to 3000 nM, where I0 and I are the emission
intensities at 598 nm in the absence and presence of DA, respec-
tively. A linear response was observed in the range of 150–
3000 nM with a correlation coefﬁcient of 0.9938 (see lower inset).
The ﬁtting curve generated a linear equation: I0 I¼248.33þ0.11
[DA]. Using six replicate detections of DA, we determined the limit
of detection (LOD) (Chandran et al., 2006) to be 7.80 nM, which
indicates that L-cys ZnS:Mn QDs possesses high sensitivity to de-
tect DA. This value is 1–2 orders of magnitude higher than those
reported for Cd-based QDs probes for detection of DA via ﬂuor-
escence and electro-generated chemiluminescence methods (Mu
et al., 2014; Liu et al., 2008b; Xiangzhao et al., 2013).Although the concentration of DA varies depending on its lo-
cation in the nervous system, it has been consistently reported
that DA concentration is at the nanomolar scale, falling within the
range of 1–50 nM in the brain extracellular ﬂuid (O’neill, 1994).
Our sensor is thus sensitive enough to detect DA in this biological
setting, especially when DA concentrations are low, e.g., in the
central nervous system. This situation represents the usual clinical
proﬁle of a neurodegenerative disorder associated to Parkinson's
disease (Yao et al., 2013), in which a major loss (480%) of dopa-
minergic neurons (responsible for DA production) is manifested
(Spina et al., 1989). Based on these observations, we assume that
the DA detection arises from a phosphorescent quenching process,
which can be accounted for in terms of a pH dependent electron
transfer from the QDs to oxidized dopamine quinone. Under al-
kaline conditions and ambient O2 exposure, dopamine oxidizes
forming dopamine quinone, which is absorbed onto the QDs
strongly interacting with the L-cysteine shell anchored to the QDs
surface via non-covalent interactions, such as hydrogen bonding
(O-H) and electrostatic interactions. Then, in parallel, the photo-
excited electrons in the conduction band undergo intersystem
crossing to the 4T1 ﬁrst excited state of Mn (see emission analysis),
followed by transfer to the lowest unoccupied molecular orbital of
Table 1
Recovery test for the detection of DA in urine samples (n¼3).
Sample Added concentration
(nM)
Found by our
method (nM)
Recovery (%) RSD (%)
1 5.0 6.3 80 2.1
2 150.0 143.9 96 1.3
3 1000.0 933.0 93 6.2
D. Diaz-Diestra et al. / Biosensors and Bioelectronics 87 (2017) 693–700698the dopamine quinone resulting in phosphorescence quenching. A
summarized illustration is depicted in Scheme 1. It is well known
that under alkaline conditions and exposure of solution-contain-
ing O2, dopamine quinone acts an efﬁcient electron acceptor and is
kept at a short distance from the donor (QDs) (Laviron et al., 1984;
Medintz et al., 2010; Wraight et al., 2004). This would explain why
electrons are captured instead of recombining in the 6A1 ground
state of Mn, thus favoring an electron transfer rather than a re-
combination process at the interface of the QDs. This mechanism
was further validated to explain the detection of DA using.
adenosine, β-cyclodextrin and trimethoxysilane-capped na-
nostructures as ﬂuorescent probes (Ban et al., 2015; Mu et al.,
2014; Zhang et al., 2015a). Accordingly, we assume that L-cys ZnS:
Mn is mimicking the function of receptor proteins of the neurons
during synapse by receiving the DA (at nanomolar range) from
axon terminals, thus enabling the passage of chemical/electrical
signals to other neurons.
3.4. Effect of other biomolecules
Besides the sensitivity requirement, high selectivity is a crucial
matter to be met in real sensors to detect DA, especially when
interfering substances co-exist within the biological samples. To
verify the selectivity of the L-cys ZnS:Mn QDs probe for DA de-
tection, the phosphorescent signals from common interfering
analytes including KCl, L-histidine, dihydroxyphenylacetic acid, L-
glutamine, L-glucose, L-aspartic acid and AA, were investigated and
compared to that of DA (see Fig. 4). In order to highlight the high
selectivity of our QDs-based sensor, we used concentrations two
orders of magnitude higher than that of the DA (interfering ana-
lytes 10 mM and DA 0.2 mM). Fig. 4 shows a pronounced selective
quenching by DA over the other biomolecules, i.e. 1.6-fold less
intense than the intensity drop produced by AA, the most com-
petitive interferent in the determination of DA. AA is found in
excess (compared to DA) in the extracellular ﬂuid of the central
nervous system, where both co-exist (Ali et al., 2007). The fact that
AA does not affect signiﬁcantly the phosphorescence intensity of
the probe is likely due to its low binding constant with L-cysteine
(Ankireddy et al., 2015; Ban et al., 2015), and this result can be
used to determine DA concentrations without further sample se-
paration. The weak interference in detecting the 200-nM con-
centration of DA in the presence of the other surrounding amino
acids, glucose and chloride shows the strong non-covalent inter-
action between DA and L-cys ZnS: Mn, even when the more
electronegative parts might repel the immersed analytes. Our
ﬁndings indicate that our proposed assay exhibits high selectivityFig. 4. Relative photoluminescence response of L-cys capped ZnS:Mn QDs probe in
the presence of 200 nM DA and other interfering analytes (10 mM).and could be used to detect DA in biological samples.
3.5. Effect of the medium
After corroborating the sensitivity and selectivity of ZnS:Mn
QDs phosphorescent probes to detect DA, we evaluated its per-
formance in a biological medium, which exhibits signiﬁcant auto-
phosphorescence background but negligible room-temperature
phosphorescence (Wang et al., 2013). Thus, the possibility of in-
vestigating a real application applying our method to determine
DA in urine was explored. Urine samples were subjected to a 100-
fold dilution process using a 10 mM PBS solution (pH 8.0) before
analyses, and the determination of DA was found using a similar
calibration curve shown in Fig. 3. Table 1 summarizes the recovery
tests for the detection of DA in urine samples of three con-
centrations (low, intermediate and high) for our method, which
was compared to the method of reference (from the average of
three replicate determinations). Our results show that the re-
covery and RSD values are in the range of 80–93% and 1.3–6.2%,
respectively, and show high consistency when both methods are
compared. RSD o6.2% indicates that the sensor shows good re-
producibility. Since urine is mainly composed of amino acids,
glucose and anions/cations, our recovery results further conﬁrm
that these co-existing biomolecules do not signiﬁcantly interfere
with the DA detection in diluted urine samples. Using this ap-
proach, similar results were reported to detect AA, vanillin, cya-
nide ions and organophosphate in urine, food, tap/ground and lake
water, respectively (Bian et al., 2013; Duran et al., 2015; Shamsipur
et al., 2014; Zhang et al., 2014). Finally, our ﬁndings reveal the
potential applicability and accuracy of our ZnS:Mn phosphorescent
probes to detect DA in biological ﬂuids with high sensitivity and
selectivity.4. Conclusions
We have successfully developed a cost-effective room-tem-
perature phosphorescence sensor to detect DA based on L-cys
capped ZnS:Mn QDs. Our sensor is highly sensitive at the nano-
molar range (LOD 8 nM), which is 1–2 orders of magnitude
higher than those reported by other techniques, including ﬂuor-
escence and electro-generated chemiluminescence. We have ob-
served that the phosphorescence of the QDs is only slightly
quenched by AA and other interfering analytes (that coexist with
DA), even at concentrations two orders of magnitude higher that
of the DA, signifying that our sensor is highly selective. The fact
that AA does not signiﬁcantly affect the phosphorescence intensity
was ascribed to its low binding constant with L-cysteine, which
can be exploited in clinical trials to determine DA without re-
sorting to complex and additional separation processes to analyze
samples. We have also shown that our method can be applied to
determine DA in urine or other body ﬂuids that are mainly com-
posed of amino acids, glucose and anions/cations. For urine, we
found recovery values as high as 93% with a low relative standard
deviation. Our detection approach based on phosphorescence
signals offers a remarkable advantage since biological ﬂuids do not
D. Diaz-Diestra et al. / Biosensors and Bioelectronics 87 (2017) 693–700 699show signiﬁcant phosphorescence response, resulting in a high
signal-to-noise ratio. Besides measuring the concentration of DA in
urine samples, this piece of research represents a step forward in
the development of water-soluble phosphorescent probes, which
could be used for imaging neurodegenerative disorders in the
central nervous system, such as the Parkinson's disease.Acknowledgements
This project was partially supported by the Institute for Func-
tional Nanomaterials (NSF Grant 1002410) and PR NASA EPSCoR
(NASA Cooperative Agreement NNX13AB22A). Authors thank the
valuable assistance of Mr. Oscar Resto for providing the HRTEM
images.Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.bios.2016.09.022.References
Alarcon-Angeles, G., Perez-Lopez, B., Palomar-Pardave, M., Ramirez-Silva, M.T.,
Alegret, S., Merkoçi, A., 2008. Enhanced host–guest electrochemical recognition
of dopamine using cyclodextrin in the presence of carbon nanotubes. Carbon
46, 898–906.
Ali, S.R., Parajuli, R.R., Ma, Y., Balogun, Y., He, H., 2007. Interference of ascorbic acid
in the sensitive detection of dopamine by a nonoxidative sensin approach. J.
Phys. Chem. B 111, 12275–12281.
Alivisatos, A.P., 1996. Semiconductor clusters, nanocrystals, and quantum dots.
Science 271, 933–937.
Ankireddy, S.R., Kim, J., 2015. Selective detection of dopamine in the presence of
ascorbic acid via ﬂuorescence quenching of InP/ZnS quantum dots. Int. J. Na-
nomed. 10, 113–119.
Augustine, M.S., Ali, P.P.M., Sapna, K., Elyas, K.K., Jayalekshmi, S., 2013. Size de-
pendent optical properties of bio-compatible ZnS:Mn nanocrystals and their
application in the immobilization of trypsin. Spectrochim. Acta, Part A 108, 223
228.
Ban, R., Zhu, J.-J., Zhang, J., 2014. Manganese-doped ZnS quantum dots as a phos-
phorescent probe for use in the bi-enzymatic determination of organopho-
sphorus pesticides. Microchim. Acta 181, 1591–1599.
Ban, R., Abdel-Halim, E.S., Zhang, J., Zhu, J.-J., 2015. β-cyclodextrin functionalised
gold nanoclusters as luminescence probes for the ultrasensitive detection of
dopamine. Analyst 140, 1046–1053.
Beltran-Huarac, J., Wang, J., Tanaka, H., Jadwisienczak, W.M., Weiner, B.R., Morell,
G., 2013. Stability of the Mn photoluminescence in bifunctional ZnS:0.05Mn
nanoparticles. J. Appl. Phys. 114, 053106.
Bi, L., Dong, X.-T., Yu, Y.-H., 2014. Room temperature phosphorescence sensor based
on manganese doped zinc sulﬁde quantum dots for detection of urea. J. Lumin.
153, 356–360.
Bian, W., Ma, J., Liu, Q., Wei, Y., Li, Y., Dong, C., Shuang, S., 2014. A novel phos-
phorescence sensor for Co2þ ion based on Mn-doped ZnS quantum dots. Lu-
minescence 29, 151–157.
Bian, W., Ma, J., Guo, W., Lu, D., Fan, M., Wei, Y., Li, Y., Shuang, S., Choi, M.M.F., 2013.
phosphorescence detection of L-ascorbic acid with surface-attached N Acetyl-L-
Cysteine and L-Cysteine Mn doped ZnS quantum dots. Talanta 116, 794–800.
Chandran, S., Singh, R.S.P., 2006. Comparison of various international guidelines for
analytical method validation. Pharmazie 62, 4–14.
Clarke, S.J., Hollmann, A., Zhang, Z., Suffern, D., Bradforth, S.E., Dimitrijevic, N.M.,
Minarik, W.G., Nadeau, J.L., 2006. Photophysics of dopamine modiﬁed quantum
dots and effects on biological systems. Nat. Mater. 5, 409–417.
Dan, L., Wang, H.-F., 2013. Mn-doped ZnS quantum dot imbedded two-fragment
imprinting silica for enhanced room temperature phosphorecence probing of
domoic acid. Anal. Chem. 85, 4844–4848.
Diaz-Diestra, D., Beltran-Huarac, J., Bracho-Rincon, D.P., González-Feliciano, J.A.,
Gonzalez, C.I., Weiner, B.R., Morell, G., 2015. Biocompatible ZnS:Mn quantum
dots for reactive oxygen generation and detection in aqueous media. J. Nano-
part. Res. 17, 461.
Duran, G.M., Contento, A.M., Rios, A., 2015. β–cyclodextrin coated CdSe/ZnS quan-
tum dots for vanillin sensoring in food samples. Talanta 131, 286–291.
Ertas, N., Kara, H.E.S., 2015. L-cysteine capped Mn-doped ZnS quantum dots as a
room temperature phosphorescence sensor for in-vitro binding assay of idar-
ubicin and DNA. Biosens. Bioelectron. 70, 345–350.
Gong, Y., Fan, Z., 2014a. Highly selective manganese-doped zinc sulﬁde quantum
dots based label free phosphorescent sensor for phosphopeptides in presenceof Zirconium (IV). Biosens. Bioelectron. 66, 533–538.
Gong, Y., Fan, Z., 2014b. Melamine-modulated mercaptopropionic acid-capped
manganese doped zinc sulﬁde quantum dots as a room-temperature phos-
phorescence sensor foe detecting clenbuterol in biological ﬂuids. Sens. Actua-
tors, B 202, 638–644.
Hyman, S.E., Malenka, R.C., 2001. Addiction and the brain: the neurobiology of
compulsion and its persistence. Nat. Rev. Neurosci. 2, 695–703.
Laviron, E., 1984. Electrochemical reactions with protonations at equilibrium. the
kinetics of the parabenzoquinone hydroquinone couple on a platinum elec-
trode. J. Electroanal. Chem. 164, 213–227.
Li, H., Li, M., Shih, W.Y., Lelkes, P.I., Shih, W.H., 2011b. Cytotoxicity test water solule
ZnS and CdS quantum dots. J. Nanosci. Nanotechnol. 11, 3543–3551.
Li, L., Liu, H., Shen, Y., Zhang, J., Zhu, J.-J., 2011a. Electrogenerated chemilumines-
cence of Au nanoclusters for the detection of dopamine. Anal. Chem. 83,
661–665.
Liao, Y., Zhou, X., Xing, D., 2014. Quantum dots and graphene oxide ﬂuorescent
switch based multivariate testing strategy for reliable detection of listeria
monocytogenes. ACS Appl. Mater. Interfaces 6, 9988–9996.
Liu, J., Chen, H., Lin, Z., Lin, J.-M., 2010. Preparation of surface imprinting polymer
capped Mn-doped ZnS quantum dots and their application for chemilumines-
cence detection of 4-nitrophenol in tap water. Anal. Chem. 82, 7380–7386.
Liu, X., Ni, X., Wang, J., Yu, X., 2008a. A novel route to photoluminescent, water
soluble Mn-doped ZnS quantum dots via photopolymerization initiated by the
quantum dots. Nanotechnology 19, 485602.
Liu, X., Cheng, L.X., Lei, J.P., Ju, H.X., 2008b. Dopamine detection based on its
quenching effect on the anodic electrochemiluminescence of CdSe quantum
dots. Analyst 133, 1161–1163.
Medintz, I.L., Stewart, M.H., Trammell, S.A., Susumu, K., Delehanty, J.B., Mei, B.C.,
Melinger, J.S., Blanco-Canosa, J.B., Dawson, P.E., Mattoussi, H., 2010. Quantum
dot/dopamine bioconjugates function as redox coupled assemblies for in vitro
and intracellular pH sensing. Nat. Mater. 9, 676–684.
Miao, Y., Zhang, Z., Gong, Y., Zhang, Q., Yan, G., 2014. Self-assembly of manganese
doped zinc sulﬁde quantum dots/CTAB nanohybrids for detection of rutin.
Biosens. Bioelectron. 52, 271–276.
Mu, Q., Xu, H., Li, Y., Ma, S., Zhong, X., 2014. Adenosine capped QDs based ﬂuor-
escent sensor for detection of dopamine with high selectivity and sensitivity.
Analyst 139, 93–98.
Naccarato, A., Gionfriddo, E., Sindona, G., Tagarelli, A., 2014. Development of a
simple and rapid solid phase microextraction-gas chromatography-triple
quadrupole mass spectrometry method for the analysis of dopamine, serotonin
and norepinephrine in human urine. Anal. Chim. Acta 810, 17–24.
O’Neill, R.D., 1994. Microvoltammetric techniques and sensors for monitoring
neurochemical dynamics in vivo. Analyst 119, 767–779.
Qin, L., Ji, C., He, L., Li, X., Kang, S., Mu, J., 2014. Interactions between quantum dots
and dopamine coupled via a peptide bridge. RSC Adv. 4, 2143–2150.
Quan, Z., Yang, D., Li, C., Kong, D., Yang, P., Cheng, Z., Lin, J., 2009. Multicolor tuning
of manganese-doped colloidal nanocrystals. Langmiur 25, 10259–10262.
Ren, H.-B., Wu, B.-Y., Chen, J.-T., Yan, X.-P., 2011. Silica-coated S2—enriched man-
ganese doped ZnS quantum dots as a photoluminescence probe for imaging
intracellular Zn2þ ions. Anal. Chem. 83, 8239–8244.
Shamsipur, M., Rajabi, H.R., 2014. Pure zinc sulﬁde quantum dot as highly selective
luminescent probe for determination of hazardous cyanide ion. Mater. Sci. Eng.
C 36, 139–145.
Sotelo-Gonzalez, E., Roces, L., Garcia-Granda, S., Fernandez-Arguelles, M.T., Costa
Fernandez, J.M., Sanz-Medel, A., 2013. Inﬂuence of Mn2þ-doped ZnS quantum
dots synthesis: evaluation of the structural and photoluminescent properties.
Nanoscale 5, 9156–9161.
Spina, M.B., Cohen, G., 1989. Dopamine turnover and glutathione oxidation: im-
plications for parkinson disease. Proc. Natl. Acad. Sci. 86, 1398–1400.
Su, H., Sun, B., Chen, L., Xu, Z., Ai, S., 2012. Colorimetric sensing of dopamine based
on the aggregation of gold nanoparticles induced by copper ions. Anal. Methods
4, 3981–3986.
Tan, L., Li, Y., Tang, Y., Kang, C., Yu, Z., Xu, S., 2012. Room temperature phosphor-
escence sensor for Hg2þ based on mn-doped ZnS quantum dots. J. Nanosci.
Nanotechnol. 12, 7788–7795.
Tobler, P.N., Fiorillo, C.D., Schultz, W., 2005. Adaptive coding of reward value by
dopamine neurons. Science 307, 1642–1645.
Wang, H.-F., Wu, Y.-Y., Yan, X.-P., 2013. Room-temperature phosphorescent dis-
crimination of cathecol from resorcinol and hydroquinone based on sodium
tripolyphosphate capped Mn-doped ZnS quantum dots. Anal. Chem. 85,
1920–1925.
Wei, X., Zhou, Z., Hao, T., Li, H., Yan, Y., 2015. Molecularly imprinted polymer na-
nospheres based on MN-doped ZnS QDs via precipitation polymerization for
room temperature phosphorescence probing of 2,6 Dichlorophenol. RSC Adv. 5,
19799–19806.
Wraight, C.A., 2004. Proton and electron transfer in the acceptor quinone complex
of photosynthetic reaction centers from rhodobacter sphaeroides. Front. Biosci.
9, 309–337.
Wu, P., He, Y., Wang, H.-F., Yan, X.-P., 2010. Conjugation of glucose oxidase onto Mn
doped ZnS quantum dots for phosphorescent sensing of glucose in biological
ﬂuids. Anal. Chem. 82, 1427–1433.
Wu, P., Zhao, T., Tian, Y., Wu, L., Hou, X., 2013. Protein-directed synthesis of Mn
doped ZnS quantum dots: a dual-channel biosensor for two proteins. Chem.
Eur. J. 19, 7473–7479.
Xiangzhao, A., Qiang, M., Xingguang, S., 2013. Nanosensor for dopamine and glu-
tathione based on the quenching and recovery of the ﬂuorescence of silica
D. Diaz-Diestra et al. / Biosensors and Bioelectronics 87 (2017) 693–700700coated quantum dots. Microchim. Acta 180, 269–277.
Yao, S.C., Hart, A.D., Terzella, M.J., 2013. An evidence-based osteopathic approach to
parkinson disease. Osteopath. Fam. Physician 3, 96–101.
Ye, X., Kuklenyik, Z., Needham, L.L., Calafat, A.M., 2005. Automated on-line column
switching HPLC-MS/MS method with peak focusing for the determination of
nine environmental phenols in urine. Anal. Chem. 77, 5407–5413.
Yildirim, A., Bayindir, M., 2014. Turn-on ﬂuorescent dopamine sensing based on
in situ formation of visible light emitting polydopamine nanoparticles. Anal.
Chem. 86, 5508–5512.
Zhang, K., Yu, T., Liu, F., Sun, M., Yu, H., Liu, B., Zhang, Z., Jiang, H., Wang, S., 2014.
Selective ﬂuorescence turn-on and ratiometric detection of organophosphate
using dual-emitting Mn-doped ZnS nanocrystal probe. Anal. Chem. 86,
11727–11733.
Zhang, L., Cui, P., Zhang, B.C., Gao, F., 2013. Aptamer-based turn-on detection ofthrombin in biological ﬂuids based on efﬁcient phosphorescence energy
transfer from Mn-doped ZnS quantum dots to carbon nanodots. Chem. Eur. J.
19, 9242–9250.
Zhang, W., Li, Y., Zhang, H., Zhou, X., Zhong, X., 2011. Facile synthesis of highly
luminescent Mn-doped ZnS nanocrystals. Inorg. Chem. 50, 10432–10438.
Zhang, X., Yang, S., Zhao, W., Sun, L., Luo, A., 2015b. Mn-doped ZnS QDs entrapped
in molecularly membranes for detection of trace bisphenol A. Anal. Methods 7,
8212–8219.
Zhang, X., Chen, X., Kai, S., Wang, H.-Y., Yang, J., Wu, F.-G., Chen, Z., 2015a. Highly
sensitive and selective detection of dopamine using one-pot synthesized highly
photoluminescent silicon nanoparticles. Anal. Chem. 87, 3360 3365.
Zhou, X., Wang, A., Yu, C., Wu, S., Shen, J., 2015. Facile synthesis of molecularly
imprinted graphene quantum dots for the determination of dopamine with
afﬁnity adjustable. ACS Appl. Mater. Interfaces 7, 11741–11747.
